logo
logo

Quanta Therapeutics, Inc. announced it raised $40.2 Million in an initial filing from an offering of $70.2 Million

Quanta Therapeutics, Inc. announced it raised $40.2 Million in an initial filing from an offering of $70.2 Million

11/04/21, 12:28 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgsan francisco
Money raised
$40.2 million
Industry
biotechnology

Company Info

Company
Quanta Therapeutics
Location
2 tower place, floor 17
san francisco, california, united states
Additional Info
Quanta Therapeutics is a private biopharmaceutical company focused on the most prevalent and elusive target in oncology—RAS. Our vision is to develop novel small molecule cancer medicines by selectively targeting protein-protein interactions that are key to oncogenic RAS activity. Driving Quanta's success is our unique high-throughput platform that applies Second Harmonic Generation (SHG) optical technology to identify allosteric modulators of membrane-bound protein complexes. The Quanta team has extensive drug development expertise and substantial research experience in the RAS space. By applying innovative medicinal chemistry and its unique protein conformation detection technology, Quanta aims to advance differentiated, next-generation RAS programs that address the resistance paradigms of targeted therapy in oncology. Quanta is headquartered in South San Francisco, CA, and has a site in Radnor, PA. Find more information at https://www.quantatx.com/ Follow us on LinkedIn: Quanta Therapeutics

Related People